In This Section

Home / About / Awards & Recognition / David King Community Clinical Scientist Award

David King Community Clinical Scientist Award

headshot-James-Lloyd-Wade-III-200x240James L. Wade III, MD, FACP, FASCO
Cancer Care Specialists of Illinois

An active leader in cancer research, Dr. Wade has developed the Cancer Care Specialists of Illinois –nationally recognized as an outstanding practice and honored with the Quality Oncology Practice Initiative Certification from the American Society of Clinical Oncology—into the largest interdisciplinary oncology/hematology practice in the state outside of Chicago. He is a board member of several NCI-sponsored national and international research organizations and has been the principal investigator of the Central Illinois Community Oncology program since 1991. An associate professor of clinical medicine, Dr. Wade also teaches and mentors young physicians at the Feinberg School of Medicine, Northwestern University in Chicago.



The David King Community Clinical Scientist Award recognizes active community clinical research leaders. Award winners have demonstrated leadership in the development, participation, and evaluation of clinical studies and/or are active in the development of new screening, risk assessment, treatment, or supportive care programs for cancer patients.

This prestigious award is named after David K. King, MD, FACP, an ACCC past president, who passed away after a brief battle with cancer. Dr. King spent his entire career caring for individuals with cancer and advocating for access to quality care, while also championing the Community Clinical Oncology Program and the value of clinical research in the community setting.

The David King Community Scientist Award recipient is recognized at the ACCC National Oncology Conference. The winner receives the following:

  • $1,000 cash award plus a plaque
  • Travel expenses (round-trip coach airfare, 2 nights hotel accommodations, meals, parking, mileage)
  • Conference registration fee waived

Application/Nomination Process

Applicants and nominators must complete and submit the Award Application/Nomination Form. The Award Selection Committee reviews the applicants and nominees and selects the candidate to recommend to the Board of Trustees for approval. The winner is then notified and recognized at the National Oncology Conference in the fall.

Eligibility Criteria

  • Nominee MUST be able to attend and personally accept award at the National Oncology Conference.
  • Nominee must have proven to be a leader in clinical trials for the development, participation and evaluation of studies (for example, research including screening and treatment, risk assessment, treatment, supportive care).
  • Nominee has developed new screening, risk assessment, treatment, or supportive care programs for cancer patients.